Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price was down 9% during mid-day trading on Thursday . The company traded as low as GBX 1.32 and last traded at GBX 1.32. Approximately 101,585 shares traded hands during trading, a decline of 79% from the average daily volume of 475,768 shares. The stock had previously closed at GBX 1.45.
Cizzle Biotechnology Price Performance
The stock’s 50-day moving average is GBX 1.55 and its 200 day moving average is GBX 1.54. The stock has a market cap of £5.23 million, a price-to-earnings ratio of -4.13 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
